Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BDTX stock hub

Black Diamond Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BDTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

171.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BDTX

In the news

Latest news · BDTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-35.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-20.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BDTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001701541
Company name	Black Diamond Therapeutics, Inc.
Country	United States
Country code	US
Cusip	09203E105
Employees	21
Employees Change	-3%
Employees Change Percent	-12.5
Enterprise value	$67.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-01-30
Isin	US09203E1055
Last refreshed	2026-05-10
Market cap	$171.3M
Market cap category	Micro-Cap
Price	$2.99
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	BDTX
Website	https://www.blackdiamondtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.22%
FCF yield	-19.86%
P/B ratio	1.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-43.2M
Net Income Growth Years	4%
Profit Per Employee	$-2.1M
Profitable Years	1
ROA	-18.57
Roa5y	-23.24
ROCE	-38.79
ROE	-35.16
Roe5y	-45.22
ROIC	-20.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	92.99%
Cagr3y	14.92%
Cagr5y	-34.87%
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$132.9M
Cash	$118.3M
Current Assets	$123M
Current Liabilities	$14.5M
Debt	$14.1M
Debt Equity	$0.14
Equity	$104.3M
Liabilities	$28.6M
Long Term Assets	$10M
Long Term Liabilities	$14.1M
Net Cash	$104.2M
Net Cash By Market Cap	$60.8
Net Cash Growth	-20.37%
Net Debt Equity	$-1
Tangible Book Value	$104.3M
Tangible Book Value Per Share	$1.82
WACC	20.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.46
Net Working Capital	$-9.8M
Quick ratio	8.14
Working Capital	$108.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.91%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	92.9%
200-day SMA	2.94
3Y total return	51.78%
50-day SMA	2.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-88.27%
All Time High	46.25
All Time High Change	-93.54%
All Time High Date	2020-06-03
All Time Low	1.18
All Time Low Change	153.39%
All Time Low Date	2022-10-17
ATR	0.22
Beta	3.34
Beta1y	2.45
Beta2y	2.32
Ch YTD	23.05
High	3.15
High52	4.94
High52 Date	2025-11-12
High52ch	-39.47%
Low	2.7
Low52	1.53
Low52 Date	2025-05-08
Low52ch	95.17%
Ma50ch	19.46%
Premarket Change Percent	0.74
Premarket Price	$2.74
Premarket Volume	2,378
Price vs 200-day SMA	1.7%
RSI	58.76
RSI Monthly	47.25
RSI Weekly	55.13
Sharpe ratio	1.21x
Sortino ratio	1.85
Total Return	-0.91%
Tr YTD	23.05
Tr1m	22.04%
Tr1w	15%
Tr3m	32.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	4
Analyst Price Target Top	$9
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.21
Earnings Revenue Estimate	30,000,000x
Earnings Revenue Estimate Growth	-57.14x
Operating Income	$-45.9M
Price target	$9.67
Price Target Change	$223
Price Target Change Top	$201

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,259,580%
Float Percent	80.73%
Shares Insiders	0.67%
Shares Institutions	58.08%
Shares Out	57,301,774
Shares Qo Q	0.25%
Shares Yo Y	0.91%
Short Float	11.83%
Short Ratio	8.5
Short Shares	9.55

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-40.4M
Average Volume	954,887.55x
Bv Per Share	1.82
Ch1m	22.04
Ch1w	15
Ch1y	92.9
Ch3m	32.59
Ch3y	51.78
Ch5y	-88.27
Ch6m	-23.14
Change	9.93%
Change From Open	9.93
Close	2.72
Days Gap	0
Depreciation Amortization	265,000
Dollar Volume	4,973,204.2
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-45.9M
EBITDA	$-45.7M
EPS	$-0.76
F Score	1
FCF	$-34M
FCF EV Yield	-50.67x
FCF Per Share	$-0.59
Financing CF	-363,000
Fiscal Year End	December
Founded	2,014
Investing CF	-33,952,000
Ipr	-84.26
Iprfo	-90.94
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-16
Ma150	2.93
Ma150ch	2.15%
Ma20	2.87
Ma20ch	4.18%
Net CF	-68,343,000
Next Earnings Date	2026-08-06
Open	2.72
Optionable	Yes
Position In Range	64.44
Post Close	2.99
Postmarket Change Percent	1.34
Postmarket Price	$3.03
Ppne	9,095,000
Pre Close	2.72
Price Date	2026-05-08
Ptbv Ratio	1.64
Relative Volume	1.74x
Share Based Comp	6,375,000
Tr6m	-23.14%
Us State	Massachusetts
Volume	1,663,279

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BDTX pay a dividend?

Capital-return profile for this ticker.

Performance

BDTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BDTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+58.1%

Float: +80.7% of shares outstanding

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BDTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.8

Neutral momentum band

Price vs 200-day MA

+1.7%

50/200-day relationship not available

Beta (5Y)

3.34

More volatile than the market

Sharpe ratio

1.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BDTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BDTX stock rating?

Black Diamond Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BDTX analysis?

The full report lives at /stocks/BDTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BDTX?

The latest report frames BDTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BDTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.